We are live on ! Find out more
CABA icon

Cabaletta Bio
CABA

63 hedge funds and large institutions have $135M invested in Cabaletta Bio in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

8.95% more ownership

Funds ownership: 67.45% → 76.4% (+8.9%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 68 → 63 (-5)

25% less capital invested

Capital invested by funds: $180M → $135M (-$44.6M)

29% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 17

78% less call options, than puts

Call options by funds: $118K | Put options by funds: $546K

Holders
63
Holders Change
-5
Holders Change %
-7.35%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
19
Reduced
16
Closed
17
Calls
$118K
Puts
$546K
Net Calls
-$428K
Net Calls Change
-$708K

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$5.48M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$3.47M
3
Millennium Management
Millennium Management
New York
+$1.12M
4
Morgan Stanley
Morgan Stanley
New York
+$840K
5
BFM
Boothbay Fund Management
New York
+$676K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$7.19M
2
CAM
Cormorant Asset Management
Massachusetts
-$2.88M
3
State Street
State Street
Massachusetts
-$1.78M
4
CCM
CAAS Capital Management
New York
-$1.64M
5
Northern Trust
Northern Trust
Illinois
-$1.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
26
ExodusPoint Capital Management
New York
$291K +$333K +33,857 New
GCP
27
GSA Capital Partners
United Kingdom
$290K +$219K +22,253 +194%
Northern Trust
28
Northern Trust
Illinois
$219K -$1.03M -104,647 -80%
Wells Fargo
29
Wells Fargo
California
$197K -$23.9K -2,431 -10%
State Street
30
State Street
Massachusetts
$196K -$1.78M -181,509 -89%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$175K +$16.6K +1,689 +9%
Bank of America
32
Bank of America
North Carolina
$174K +$100K +10,227 +102%
Jane Street
33
Jane Street
New York
$141K +$2.2K +224 +1%
Renaissance Technologies
34
Renaissance Technologies
New York
$128K +$146K +14,900 New
PP
35
PDT Partners
New York
$124K +$141K +14,400 New
AGM
36
Alpine Global Management
New York
$121K +$138K +14,072 New
CSS
37
Cubist Systematic Strategies
Connecticut
$120K +$137K +13,928 New
IWM
38
IHT Wealth Management
Illinois
$114K +$130K +13,215 New
Two Sigma Investments
39
Two Sigma Investments
New York
$109K -$207K -21,093 -62%
JP Morgan Chase
40
JP Morgan Chase
New York
$108K -$176K -17,895 -59%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$106K -$35.4K -3,600 -23%
Osaic Holdings
42
Osaic Holdings
Arizona
$95K +$105K +10,700 +3,567%
V
43
Veritable
Delaware
$90K – – –
Bank of New York Mellon
44
Bank of New York Mellon
New York
$89K -$397K -40,435 -80%
Simplex Trading
45
Simplex Trading
Illinois
$47K +$46.8K +4,764 +583%
TRCT
46
Tower Research Capital (TRC)
New York
$30K +$17.7K +1,802 +114%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$13K +$1.18K +120 +9%
Citigroup
48
Citigroup
New York
$13K +$1.93K +196 +15%
US Bancorp
49
US Bancorp
Minnesota
$8K – – –
EWM
50
Endurance Wealth Management
Rhode Island
$6K – – –
1
2
3 4

CABA Hedge Fund Activity: Q2 2021 in Review

63 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q2 2021, worth a combined $135M — down 25% from $180M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CABA and 12 opened new positions — a net loss of 5 holders — while 16 trimmed existing stakes and 19 added.

The largest buyer was Ikarian Capital, adding an estimated $5.48M. The largest seller was BlackRock, cutting an estimated $7.19M.

  • 63 institutional investors held Cabaletta Bio (CABA) as of Q2 2021, down from 68 in Q1 2021.
  • Funds reported $135M of Cabaletta Bio stock for Q2 2021, down 25% quarter-over-quarter.
  • 12 funds opened new Cabaletta Bio positions in Q2 2021 and 17 closed out, a net change of -5 holders.
  • The largest Cabaletta Bio buyer in Q2 2021 was Ikarian Capital, an estimated $5.48M added.
  • The largest Cabaletta Bio seller in Q2 2021 was BlackRock, an estimated $7.19M sold.

Based on aggregated 13F filings for Q2 2021.